Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action

Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action

The use of onabotulinumtoxinA (BoNT-A) for the treatment of lower urinary tract diseases (LUTD) has increased markedly in recent years. The indications for BoNT-A treatment of LUTD now include neurogenic or idiopathic detrusor overactivity, interstitial cystitis/bladder pain syndrome and voiding dys...

Full description

Bibliographic Details
Main Authors: Jia-Fong Jhang, Hann-Chorng Kuo
Format: Article
Language:English
Published: MDPI AG 2016-04-01
Series:Toxins
Subjects:
interstitial cystitis
overactive bladder
treatment
Online Access:http://www.mdpi.com/2072-6651/8/4/120

Internet

http://www.mdpi.com/2072-6651/8/4/120

Similar Items